Lifebit

🔬 Accelerate your drug discovery process with secure data solutions! Identifying viable drug targets is crucial in pharmaceutical research. Our latest blog explores how Lifebit’s advanced secure data platforms can enhance this process. By leveraging interoperable biomedical data, data harmonization, and bioinformatics pipelines, we provide a holistic approach to drug target identification. Discover how our global network of over 100 million patient datasets and our federated end-to-end trusted research environment are designed to maximize research discoveries whilst ensuring ultimate data privacy and security. Read the full blog and learn how to streamline your drug development processes: https://bit.ly/3yrZFjX #PharmaceuticalResearch #DrugDiscovery #Bioinformatics #SecureData #PrecisionMedicine #Lifebit

🔬NEW White Paper: US & EU policy guidance on AI in drug discovery AI is making a transformative impact on many industries, and the policy guidance for life sciences on the integration of AI is rapidly evolving. With many of our clients in the pharma sector focused on drug development, we’ve taken a step back to review recent policy developments around AI in life sciences and summarized these in our latest whitepaper. In a world where political landscapes are constantly shifting, particularly with the upcoming US elections and new governments in Europe, this white paper provides a timely reflection on the views of governments and administrations. The Biden-Harris administration and the UK government are leading the way with a focus on safe and equitable AI, especially in industries with a direct impact on society. But is there clear guidance on what this means for life sciences & drug discovery? 🔍 Read our white paper to find out: 🔹 The historical evolution and current applications of AI in drug discovery 🔹 The promising future of AI in personalized medicine 🔹 Key policy guidance from the United States and Europe 🔹 Ethical considerations and global AI safety initiatives 🌐 Download the full white paper to stay informed on how AI is driving the future of drug development and the latest regulatory insights. And let us know what you think? https://bit.ly/4d3Yw14 #AIDrugDiscovery #PharmaInnovation #Lifebit #AIinPharma #RegulatoryGuidance #HealthcareAI

🔬 Unlocking the Future of Drug Discovery with Imaging Data! 🔬 Today we're pleased to share our latest blog highlighting the pivotal role of imaging data in revolutionizing scientific insights and discovery 📊🔍 Target validation is a critical step in drug discovery, ensuring that a biological target is directly involved in disease processes and that modulating it will have therapeutic effects. How Imaging Data is Revolutionizing This Process: 🔹 Enhanced Molecular Understanding: Techniques like PET and MRI allow non-invasive visualization of biological processes, helping researchers understand drug interactions at a molecular level. 🔹 Real-time Visualization: Advanced imaging methods provide real-time insights into drug-target interactions, improving the accuracy of target validation. 🔹 Advancing Oncology: Imaging technologies combined with AI are paving the way for more precise and effective cancer treatments. Discover how these advances are accelerating drug development and bringing us closer to a new era of personalized medicine. 🌟 🔗 Read the full blog here: https://bit.ly/3SuTtP5 #DrugDiscovery #PrecisionMedicine #Pharma #BiomedicalResearch #TargetValidation #ImagingData #Lifebit

🔬 Advances in Oncological Data Analysis: Transforming Patient Outcomes 🔬 Cancer research and patient care are being revolutionized by the power of data. In our latest blog, we explore how advancements in oncology data analysis are uncovering new therapies and validating existing treatments. From leveraging real-world data to integrating genomic information, these advancements are paving the way for personalized cancer treatment plans. Despite challenges like data integration and privacy concerns, the future of oncology looks promising with data-driven approaches. Learn more about the complexities of oncology data and uncover how it’s shaping the future of cancer care. 🔗 Read the full article: https://bit.ly/46heORs #Oncology #CancerResearch #BigData #PrecisionMedicine #HealthcareInnovation #Bioinformatics #RealWorldData

🌟 Cardiology Data Evolution: Advancing Women’s Health 🌟 Heart disease remains the leading cause of death among women in the U.S., yet it often goes undiagnosed or misdiagnosed, leading to significantly higher mortality rates. Big data in cardiology is poised to change this. In our latest blog, we explore how large-scale cardiology data can revolutionize the diagnosis and treatment of heart disease, particularly for women. From identifying gender-specific differences in cardiovascular risk to leveraging AI for early detection, the potential is immense. Discover how data can drive precision medicine and improve outcomes for women. Read more about the importance of privacy and security in this evolving field. 🔗 Read the full article: https://bit.ly/46kOYMp #Cardiology #WomensHealth #BigData #HealthcareInnovation #PrecisionMedicine #AIinHealthcare

In our latest blog we consider the valuable role of longitudinal health data in building knowledge and understanding of diseases and how to prevent, treat and cure them. Increasingly used in research, longitudinal data is health information that is collected from individuals over extended periods, offering a comprehensive view of their health history and outcomes. It tracks changes and developments in health over time, providing valuable insights into disease progression, treatment effectiveness and population health trends. Used to tailor personalised treatments, identify risk factors and inform public health strategies, safe access, use and analysis of longitudinal data is improving patient care and health outcomes. Read our blog to learn more. https://bit.ly/3zGwx91 #HealthData #DataScience #Lifebit #DataNetwork #DataAccess #DataAnalysis #LongitudinalData

What a fantastic day we had at the Genomics England Research Summit yesterday! From great conversations with colleagues, partners, students, and patient participants at our booth, to attending diverse and fascinating talks on the future of genomics - the summit was an incredible opportunity to learn about the latest approaches and challenges in genomics research and medicine while making new connections. We were very proud to co-present two research posters with our amazing research collaborators: Thiloka Ratnaike from University of Cambridge and Tomas Fitzgerald at European Bioinformatics Institute | EMBL-EBI Thank you to the whole team at Genomics England for putting on such an informative and engaging event. Roll on next year! Thorben Seeger Rosie Davies Sangram Keshari Sahu Christina Chatzipantsiou Dr. Maria C. Dunford Pablo Prieto Barja, PhD Simeón Baker Richard Scott Chiara Bacchelli Amanda White #GERS2024 #GenomicsEngland #ResearchSummit #Lifebit #Genomics #Collaboration #Innovation

🚀 Join us today! 🚀 The Lifebit team is delighted to be at the Genomics England Research Summit today at the Business Design Centre in London! 🌟 We're showcasing our latest innovations in supporting secure data access & research at booth 6. Stop by to meet our experts, discuss your challenges, and explore how Lifebit can power your research. Come and say hello to our team and let's advance precision medicine together. #GenomicsEngland #ResearchSummit #Lifebit #Innovation #Genomics #Healthcare

🔬 The latest report from the Public Policy Projects' team calls for significant reforms in approaches to genomic testing in cancer care, highlighting key challenges and solutions. By addressing process and capacity issues, enhancing pathology lab resources, creating a centralised clinical trials database and increasing clinician education and awareness, the report aims to improve patient outcomes and ensure equitable access to genomic testing across the UK. 💊 Despite advancements, disparities in access remain, underscoring the need for a cultural shift in genomic medicine. You can find the full report below 👇

We are pleased to introduce the Lifebit Clinical Portal v2 - our end-to-end solution to enable clinicians to enhance patient care through improved data management, integrated EHR and genomic data and AI to deliver more accurate diagnostics, and personalized treatments for patients. The key features of our Clinical Portal include: ✅ Robust patient management: Integrate patient histories, treatment plans and ongoing care information. ✅ Automated recruitment & consent management: Streamline and track patient consents quickly & securely, facilitating faster approvals for critical tests and treatments. ✅ Criteria-based notifications: Deploy automated alerts that notify healthcare teams immediately when patients meet predetermined diagnostic or therapeutic criteria. ✅ Seamless clinical note integration: Directly integrate and synchronize clinical notes within patients’ EHR systems, maintaining a single, consistent, and comprehensive patient health record. ✅ Pharmacogenomic reporting: Produce individual participant pharmacogenomic reports to guide clinicians for treatment and dosage recommendations. ✅ Comprehensive genomic data analysis: Scrutinize patient-specific genomic data to detect significant genetic variants that could inform therapeutic strategies. ✅ Dynamic variant filtering and therapy recommendations: Deliver precise therapy recommendations, streamlining the clinical decision-making process. The Lifebit Clinical Portal integrates AI & advanced software capabilities with genomic and health data to streamline patient workflows and ensure more efficient & accurate data management. We are supporting healthcare providers across the world to increase diagnostic accuracy and improve individualized patient care, setting new benchmarks in precision medicine. You can learn more about how our platform meets the complex needs of modern medical institutions in our latest blog: https://bit.ly/3zvkfAd #PrecisionMedicine #Genomics #AI #PatientData #Lifebit